Human chorionic gonadotropin is a heterodimeric glycoprotein hormone composed of alpha and beta subunits. It shares its alpha subunit with other glycoprotein hormones, while the beta subunit contributes much of its receptor specificity. HCG binds to the luteinizing hormone/chorionic gonadotropin receptor, or LHCGR, a G-protein-coupled receptor expressed in reproductive tissues including the ovary and testis.
Activation of LHCGR initiates intracellular signaling that includes cyclic AMP pathways and downstream steroidogenic responses. In ovarian research, HCG signaling is closely associated with corpus luteum function and progesterone production. In testicular models, LHCGR activation is linked with Leydig-cell activity and androgen biosynthesis. These pathways make HCG an important research tool for studying how upstream gonadotropin signaling influences downstream reproductive-hormone production.
HCG and luteinizing hormone act through the same receptor, but they are not biologically identical. Research suggests that the receptor can distinguish between the two ligands and produce differences in signaling kinetics and downstream responses. This makes HCG useful not only as a reproductive hormone model, but also as a tool for studying ligand-specific receptor signaling.



